Bedrijfsvoering GSK plc

Aandelen

GSK

GB00BN7SWP63

Farmaceutische producten

Beurs gesloten - London S.E. 17:35:06 19-09-2024 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
1.574,50 GBX -1,84% Intraday-grafiek van GSK plc -4,84% +8,57%

Uitvoerend comité: GSK plc

Bedrijfsleider
Beklede functiesVan
Emma Walmsley

Emma Walmsley

55 jaar

Chief Executive Officer 01-04-2017
Julie Brown

Julie Brown

62 jaar

Director of Finance/CFO 01-05-2023
Shobie Ramakrishnan

Shobie Ramakrishnan

Chief Tech/Sci/R&D Officer 01-12-2021
Mick Readey

Mick Readey

Investor Relations Contact 01-03-2021
Timothy Woodthorpe

Timothy Woodthorpe

Treasurer 01-01-2000
Graham Rivers

Graham Rivers

Comptroller/Controller/Auditor 01-01-1998
James Ford

James Ford

Compliance Officer 01-08-2018
General Counsel 01-08-2018
Tony Wood

Tony Wood

Chief Tech/Sci/R&D Officer 19-01-2022
Diana Conrad

Diana Conrad

Human Resources Officer 01-01-2016
Victoria Whyte

Victoria Whyte

Corporate Secretary 27-01-2009
Amy Altshul

Amy Altshul

Chief Tech/Sci/R&D Officer -
General Counsel -

Samenstelling van de raad van bestuur: GSK plc

Directeur
RadenVan
Jonathan Symonds

Jonathan Symonds

66 jaar

Governance Committee Chair 01-09-2019
Nominating Committee Chair 01-09-2019
Elizabeth Anderson

Elizabeth Anderson

66 jaar

Compensation Committee Chair
Governance Committee Chair
Nominating Committee Chair
Governance Committee 10-07-2019
Nominating Committee 10-07-2019
Audit Committee 01-09-2022
Compensation Committee 01-09-2022
Wendy Becker

Wendy Becker

58 jaar

Governance Committee Chair
Nominating Committee Chair
Compensation Committee
Nominating Committee 18-06-2019
Compensation Committee Chair 01-10-2023
Audit Committee 01-10-2023
Charles Bancroft

Charles Bancroft

65 jaar

Compensation Committee 18-07-2022
Governance Committee 06-05-2021
Nominating Committee 06-05-2021
Audit Committee Chair 13-03-2021
Anne Beal

Anne Beal

62 jaar

Compensation Committee 18-07-2022
Governance Committee 18-07-2022
Nominating Committee 18-07-2022
Jesse Goodman

Jesse Goodman

72 jaar

Governance Committee 20-03-2024
Nominating Committee 20-03-2024
Harry Dietz

Harry Dietz

66 jaar

Governance Committee 11-03-2024
Nominating Committee 11-03-2024
Emma Walmsley

Emma Walmsley

55 jaar

Compensation Committee 04-12-2019
Julie Brown

Julie Brown

62 jaar

Audit Committee Chair 05-08-2024
Jeannie T. Lee

Jeannie T. Lee

Director/Board Member 04-03-2024
Vishal Sikka

Vishal Sikka

57 jaar

Director/Board Member 18-07-2022
Independent Dir/Board Member 18-07-2022
Hal Barron

Hal Barron

62 jaar

Director/Board Member 01-01-2018

Voormalige zaakvoerders en bestuurders: GSK plc

Insider
Beklede functies
VanTot
Roy Anderson
Roy Anderson
Director/Board Member 01-10-2007 03-05-2018
Independent Dir/Board Member 18-04-2011 03-05-2018
Andrew Witty
Andrew Witty
Director/Board Member 31-01-2008 31-03-2017
Chief Executive Officer 21-05-2008 31-03-2017
Corporate Officer/Principal 01-01-2003 21-05-2008
Moncef Slaoui
Moncef Slaoui
Director/Board Member 13-10-2009 31-03-2017
Chief Tech/Sci/R&D Officer 01-06-2006 22-10-2014
Corporate Officer/Principal 22-10-2014 31-03-2017
Daniel Podolsky
Daniel Podolsky
Director/Board Member 01-07-2006 05-05-2016
Independent Dir/Board Member 18-04-2011 05-05-2016
Deryck Charles Maughan
Deryck Charles Maughan
Director/Board Member 01-07-2004 05-05-2016
Independent Dir/Board Member 18-04-2011 05-05-2016
Stephanie Burns
Stephanie Burns
Director/Board Member 12-02-2007 05-05-2016
Independent Dir/Board Member 18-04-2011 05-05-2016
Tom de Swaan
Tom de Swaan
Director/Board Member 01-01-2006 08-05-2015
Independent Dir/Board Member 10-02-2011 08-05-2015
Christopher Gent
Christopher Gent
Chairman 01-06-2004 01-03-2015
Independent Dir/Board Member 01-06-2004 01-03-2015
Robert Wilson
Robert Wilson
Director/Board Member 01-11-2003 07-05-2014
Independent Dir/Board Member 18-04-2011 07-05-2014
Crispin Davis
Crispin Davis
Director/Board Member 01-07-2003 01-01-2013
Independent Dir/Board Member 18-04-2011 01-01-2013
Eddie J. Gray
Eddie J. Gray
Corporate Officer/Principal 01-01-2001 01-01-2013
H. Culp
H. Culp
Director/Board Member 01-07-2003 30-09-2012
Independent Dir/Board Member 18-04-2011 30-09-2012
Julian Heslop
Julian Heslop
Director/Board Member 13-10-2009 13-10-2009
Director of Finance/CFO 01-04-2005 31-03-2011
Russell Greig
Russell Greig
Corporate Officer/Principal 01-04-2003 01-04-2010
Ronaldo Hermann Schmitz
Ronaldo Hermann Schmitz
Director/Board Member 23-05-2000 20-05-2009
Ian Maurice Gray Prosser
Ian Maurice Gray Prosser
Director/Board Member 23-05-2000 01-05-2009
Independent Dir/Board Member 23-05-2000 20-05-2009
Michael D. Rogers
Michael D. Rogers
Corporate Officer/Principal 01-01-2001 01-01-2007
M. Berrey
M. Berrey
Corporate Officer/Principal 01-01-2004 01-01-2007
Jennie Younger
Jennie Younger
Public Communications Contact 01-12-2001 01-06-2006
Lucy Shapiro
Lucy Shapiro
Director/Board Member 01-01-2001 17-05-2006
Peter J. Job
Peter J. Job
Director/Board Member - 31-12-2004
Christopher Hogg
Christopher Hogg
Director/Board Member - 31-12-2004
John Hector McArthur
John Hector McArthur
Director/Board Member - 17-05-2004
Michèle Barzach
Michèle Barzach
Director/Board Member 01-01-1997 17-05-2004
Independent Dir/Board Member 01-01-1997 17-05-2004
Donald F. McHenry
Donald F. McHenry
Director/Board Member - 17-05-2004
Paul A. Allaire
Paul A. Allaire
Director/Board Member - 05-06-2003
F. Roger Hurn
F. Roger Hurn
Director/Board Member - 05-06-2003
James R. Beery
James R. Beery
General Counsel 01-12-2000 01-06-2001
Charles Bramlage
Charles Bramlage
Corporate Officer/Principal 01-01-1983 01-04-2001
Rupert Bondy
Rupert Bondy
General Counsel 01-01-2001 -
Ford Calhoun
Ford Calhoun
Chief Tech/Sci/R&D Officer 01-01-2001 -
Christopher Chipman
Christopher Chipman
Corporate Officer/Principal 01-08-1998 01-03-2000
Tamar Howson
Tamar Howson
Corporate Officer/Principal 01-01-1991 01-01-2000
Anthony S. Murabito
Anthony S. Murabito
Chief Tech/Sci/R&D Officer 01-01-1981 01-01-2000
Ursula B. Bartels
Ursula B. Bartels
Corporate Officer/Principal 01-01-1988 01-01-1999
Elaine Jones
Elaine Jones
Corporate Officer/Principal - 31-12-1998
Geoffrey Nichol
Geoffrey Nichol
Corporate Officer/Principal 01-12-1989 01-01-1996
Leon Palandjian
Leon Palandjian
Corporate Officer/Principal 01-01-1991 31-12-1994
Paul W. Hawran
Paul W. Hawran
Treasurer 01-07-1984 01-05-1993
Albert W. Gianchetti
Albert W. Gianchetti
Corporate Officer/Principal - -
Jim Weiss
Jim Weiss
Corporate Officer/Principal - -
Jamie Oakes
Jamie Oakes
Corporate Officer/Principal - -
David Searls
David Searls
Corporate Officer/Principal - -
Irene Hrusovsky
Irene Hrusovsky
Chief Tech/Sci/R&D Officer - -
Colin W. Dykes
Colin W. Dykes
Corporate Officer/Principal - -
Martin N. Mercer
Martin N. Mercer
Corporate Officer/Principal - -
Janet Hammond
Janet Hammond
Corporate Officer/Principal - -
Victor Paulus
Victor Paulus
General Counsel - -
Barry Brand
Barry Brand
Corporate Officer/Principal - -
Olivier Jean Bohuon
Olivier Jean Bohuon
Corporate Officer/Principal - -
John H. Dillon
John H. Dillon
Corporate Officer/Principal - -
Chris Diener
Chris Diener
Corporate Officer/Principal - -
Susan M. Welsh
Susan M. Welsh
Corporate Officer/Principal - -
L. William McIntosh
L. William McIntosh
Corporate Officer/Principal - -
Heather Giles
Heather Giles
Corporate Officer/Principal - -
Marshall Hayward
Marshall Hayward
Director/Board Member - -
Paul A. Litka
Paul A. Litka
Corporate Officer/Principal - -
Anthony P. Hurley
Anthony P. Hurley
Corporate Officer/Principal - -
Ben Nelson
Ben Nelson
Corporate Officer/Principal - -
David Pulman
David Pulman
Corporate Officer/Principal 01-01-2001 -
John A. Young
John A. Young
Director/Board Member - -
Simon M. Bicknell
Simon M. Bicknell
Corporate Officer/Principal 11-02-2011 -
Luigi Xerri
Luigi Xerri
Corporate Officer/Principal - -
John W. Morgan
John W. Morgan
General Counsel - -
Donnie Hardison
Donnie Hardison
Sales & Marketing - -
Robert Bedford
Robert Bedford
Corporate Officer/Principal - -
Frank Cattie
Frank Cattie
Corporate Officer/Principal - -
Gitte Neubauer
Gitte Neubauer
Corporate Officer/Principal - -
Thomas M. Rossi
Thomas M. Rossi
Corporate Officer/Principal - -
Gwendolyn Powell Painter
Gwendolyn Powell Painter
Chief Tech/Sci/R&D Officer - -
Eduardo Bravo Fernández de Araoz
Eduardo Bravo Fernández de Araoz
Corporate Officer/Principal - -
Pieter Muntendam
Pieter Muntendam
Corporate Officer/Principal - -
Michel G. Lurquin
Michel G. Lurquin
Director/Board Member - -
Chief Tech/Sci/R&D Officer - -
William John Edward Burt
William John Edward Burt
Corporate Officer/Principal - -
Paul Nicholson
Paul Nicholson
Corporate Officer/Principal - -
Akiyoshi Uchiyama
Akiyoshi Uchiyama
Chief Tech/Sci/R&D Officer - -
Barry S. Butler
Barry S. Butler
Corporate Officer/Principal - -
James E. Goldschmidt
James E. Goldschmidt
Corporate Officer/Principal - -
Thomas P. Blackburn
Thomas P. Blackburn
Director/Board Member - -
John Easter
John Easter
Corporate Officer/Principal - -
Jeffrey Sardis
Jeffrey Sardis
Corporate Officer/Principal - -
Jeffrey Walsh
Jeffrey Walsh
Corporate Officer/Principal - -
Michael J. Capaldi
Michael J. Capaldi
Corporate Officer/Principal - -

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man 22
Vrouw 15

Waarvan leden van het uitvoerend comité

Man 5
Vrouw 6

Waarvan bestuurders

Man 8
Vrouw 4
ESG Refinitiv
B

Milieu

Emissies
Innovatie
Gebruik van middelen

Sociaal

Maatschappelijk engagement
Mensenrechten
Productaansprakelijkheid
HR

Bedrijfsvoering

MVO-strategie
Beheer
Aandeelhouders

Controverse

Controverse
Logo GSK plc
GSK plc is een wereldwijd biofarmaceutisch bedrijf. De segmenten van het bedrijf omvatten commerciële activiteiten en onderzoek en ontwikkeling. Het ontwikkelt medicijnen tegen kanker voor patiënten, waaronder eierstokkanker, endometriumkanker en multipel myeloom. De productgebieden omvatten vaccins, speciale geneesmiddelen en algemene geneeskunde. Het bedrijf richt zich ook op de onbeantwoorde behandelingsbehoeften van patiënten met aandoeningen van de luchtwegen en ontstekingen. Haar vaccinportfolio omvat meer dan 20 vaccins die mensen helpen beschermen tegen een reeks ziekten en infecties, waaronder meningitis, gordelroos en griep. Haar gespecialiseerde geneesmiddelen houden zich ook bezig met de ontwikkeling van geneesmiddelen voor aandoeningen van de luchtwegen en HIV. De algemene geneesmiddelen omvatten inhalatiemedicijnen voor astma en chronische obstructieve longziekte, antibiotica en geneesmiddelen voor huidziekten. Het ontwikkelt therapeutica op basis van oligonucleotiden voor chronische hepatitis B en steatotische leveraandoeningen, evenals andere therapeutische gebieden buiten de leveraandoeningen.
Werknemers
70.212
Meer informatie over het bedrijf

Sleutelfiguren die het bedrijf verlieten

Richard Sykes
-
Richard Sykes

Chief Executive Officer

01-01-1995 01-01-2002

Jean-Pierre Garnier
-
Jean-Pierre Garnier

Chief Executive Officer

23-05-2000 21-05-2008

Christopher Gent
-
Christopher Gent

Chairman

01-06-2004 01-03-2015

Andrew Witty
-
Andrew Witty

Chief Executive Officer

21-05-2008 31-03-2017

Philip Hampton
-
Philip Hampton

Chairman

07-05-2015 01-09-2019

-40 % Aanbod van beperkte duur: Onze abonnementen leiden je naar de beste beleggingen van morgen. De laatste uren!
PROFITEER NU